These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 30474852)

  • 1. Does seminal vesicle-sparing robotic radical prostatectomy influence postoperative prostate-specific antigen measured with an ultrasensitive immunoassay?
    Burkhardt O; Neuenschwander JE; John H; Randazzo M
    Swiss Med Wkly; 2018 Nov; 148():w14685. PubMed ID: 30474852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of the nadir value of serum prostate-specific antigen measured by an ultrasensitive assay as a predictor of biochemical recurrence after radical prostatectomy for clinically localized prostate cancer.
    Sakai I; Harada K; Kurahashi T; Muramaki M; Yamanaka K; Hara I; Inoue TA; Miyake H
    Urol Int; 2006; 76(3):227-31. PubMed ID: 16601384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of seminal vesicle-sparing radical prostatectomy on serum prostate-specific antigen level.
    John H; Hauri D; Maake C
    BJU Int; 2003 Dec; 92(9):920-3. PubMed ID: 14632847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression.
    Salomon L; Anastasiadis AG; Johnson CW; McKiernan JM; Goluboff ET; Abbou CC; Olsson CA; Benson MC
    Urology; 2003 Aug; 62(2):304-9. PubMed ID: 12893340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of postoperative nadir prostate-specific antigen value by ultrasensitive assay as a predictor of prostate-specific antigen relapse for pathological T3 or positive surgical margins after radical prostatectomy for prostate cancer.
    Yoshida T; Matsuzaki K; Kobayashi Y; Takeda K; Nakayama M; Arai Y; Kakimoto K; Nishimura K
    Int Urol Nephrol; 2012 Apr; 44(2):479-85. PubMed ID: 21822599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of ultrasensitive prostate-specific antigen assay for early detection of biochemical failure after radical prostatectomy.
    Nakamura M; Hasumi H; Miyoshi Y; Sugiura S; Fujinami K; Yao M; Kubota Y; Uemura H
    Int J Urol; 2005 Dec; 12(12):1050-4. PubMed ID: 16409609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recurrence following radical surgery for prostatic cancer. Analysis of clinical, biological and anatomo-pathological prognostic factors].
    Feyaerts A; Delrée A; Lorge F; Opsomer RJ; Wese FX; Van Cangh PJ; Draguet AP; Cosyns JP
    Acta Urol Belg; 1997 Mar; 65(1):11-8. PubMed ID: 9245198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasensitive prostate specific antigen assay following laparoscopic radical prostatectomy--an outcome measure for defining the learning curve.
    Viney R; Gommersall L; Zeif J; Hayne D; Shah ZH; Doherty A
    Ann R Coll Surg Engl; 2009 Jul; 91(5):399-403. PubMed ID: 19409146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.
    Shen S; Lepor H; Yaffee R; Taneja SS
    J Urol; 2005 Mar; 173(3):777-80. PubMed ID: 15711268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of undetectable ultrasensitive prostate-specific antigen nadir after radical prostatectomy.
    Hong SK; Park HZ; Lee WK; Kim DS; Lee JS; Doo SH; Jeong SJ; Yoon CY; Byun SS; Lee SE
    Urology; 2010 Sep; 76(3):723-7. PubMed ID: 20579699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early prostate-specific antigen failure following radical perineal versus retropubic prostatectomy: the importance of seminal vesicle excision.
    Theodorescu D; Lippert MC; Broder SR; Boyd JC
    Urology; 1998 Feb; 51(2):277-82. PubMed ID: 9495711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of single positive surgical margin features on biochemical recurrence after robotic radical prostatectomy.
    Evren I; Hacıislamoğlu A; Ekşi M; Yavuzsan AH; Baytekin F; Çolakoğlu Y; Canoğlu D; Tugcu V
    Int Braz J Urol; 2019; 45(1):45-53. PubMed ID: 30325603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of seminal vesicle involvement due to prostate cancer in radical prostatectomy specimens.
    Algarra R; Barba J; Merino I; Tienza A; Tolosa E; Robles JE; Zudaire J
    Actas Urol Esp; 2015 Apr; 39(3):144-53. PubMed ID: 24996780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does bilateral seminal vesicle invasion at radical prostatectomy predict worse prognosis than unilateral invasion among patients with pT3b prostate cancers?
    Lee HJ; Han JH; Lee DH; Nam JK; Kim TN; Chung MK; Park SW
    Int J Urol; 2016 Sep; 23(9):758-63. PubMed ID: 27305865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
    Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
    J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative prostate specific antigen and prostate volume are significant predictors of seminal vesicle invasion in patients with prostate cancer.
    Sfoungaristos S; Perimenis P
    Prague Med Rep; 2011; 112(4):263-71. PubMed ID: 22142521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.